At 52 weeks, Lilly reports 1.5% more weight loss on 17.2 mg Foundayo, but the data compares two separate trials rather than a head-to-head study.
Recap by typeshit. Full story at Yahoo Finance.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
TRM says crypto payments to vendors listing both rose 32% to $37.3M in 2025, with US buyers making up about 57% of the payments it could trace to a country.
Researchers pooled 6,898 participants and also saw bigger drops in HbA1c and waist size, though stomach side effects ran higher than with either drug alone.
Loading…